The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD

References

• Sanada H, Yokokawa H, Yoneda M, Yatabe J, Sasaki Yatabe M, Williams SM, Felder RA, Jose PA. High body mass index is an important risk factor for the development of type 2 diabetes. Intern Med 2012; 51:1821-6; PMID:22821094; http://dx.doi.org/10.2169/internalmedicine.51.7410
   PubMedGoogle Scholar
• Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, Ernst ND, Horan M. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000; 8:605-19; PMID:11225709; http://dx.doi.org/10.1038/oby.2000.79
   PubMedGoogle Scholar
• Lamon-Fava S, Wilson PW, Schaefer EJ. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1996; 16:1509-15; PMID:8977456; http://dx.doi.org/10.1161/01.ATV.16.12.1509
   PubMed Web of Science ®Google Scholar
• Miyake T, Kumagi T, Hirooka M, Furukawa S, Koizumi M, Tokumoto Y, Ueda T, Yamamoto S, Abe M, Kitai K, et al. Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study. J Gastroenterol 2013; 48:413-22; PMID:22933183; http://dx.doi.org/10.1007/s00535-012-0650-8
   PubMedGoogle Scholar
• Anjana M, Sandeep S, Deepa R, Vimaleswaran KS, Farooq S, Mohan V. Visceral and central abdominal fat and anthropometry in relation to diabetes in Asian Indians. Diabetes Care 2004; 27:2948-53; PMID:15562212; http://dx.doi.org/10.2337/diacare.27.12.2948
   PubMedGoogle Scholar
• Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY. Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans. Diabetes Care 2003; 26:650-5; PMID:12610016; http://dx.doi.org/10.2337/diacare.26.3.650
   PubMed Web of Science ®Google Scholar
• Wei M, Gaskill SP, Haffner SM, Stern MP. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans-a 7-year prospective study. Obes Res 1997; 5:16-23; PMID:9061711; http://dx.doi.org/10.1002/j.1550-8528.1997.tb00278.x
   PubMedGoogle Scholar
• Dowse GK, Zimmet PZ, Gareeboo H, George K, Alberti MM, Tuomilehto J, Finch CF, Chitson P, Tulsidas H. Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care 1991; 14:271-82; PMID:2060430; http://dx.doi.org/10.2337/diacare.14.4.271
   PubMed Web of Science ®Google Scholar
• Araneta MR, Barrett-Connor E. Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and white women. Obes Res 2005; 13:1458-65; PMID:16129729; http://dx.doi.org/10.1038/oby.2005.176
   PubMedGoogle Scholar
• Mamo JC, Watts GF, Barrett PH, Smith D, James AP, Pal S. Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? Am J Physiol Endocrinol Metab 2001; 281:E626-32; PMID:11500319
   PubMed Web of Science ®Google Scholar
• Chan DC, Barrett HP, Watts GF. Dyslipidemia in visceral obesity: mechanisms, implications, and therapy. Am J Cardiovas Drugs 2004; 4:227-46; PMID:15285698; http://dx.doi.org/10.2165/00129784-200404040-00004
   PubMedGoogle Scholar
• Zambon A, Marchiori M, Manzato E. Dyslipidemia in visceral obesity: pathophysiological mechanisms, clinical implications and therapy. G Ital Cardiol (Rome) 2008; 9:29S-39S.
   Google Scholar
• Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113:898-918; PMID:16380542; http://dx.doi.org/10.1161/CIRCULATIONAHA.106.171016
   PubMed Web of Science ®Google Scholar
• Kim SK, Kim HJ, Hur KY, Choi SH, Ahn CW, Lim SK, Kim KR, Lee HC, Huh KB, Cha BS. Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases. Am J Clin Nutr 2004; 79:593-9; PMID:15051602
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Nakamura T, Shimomura I, Kotani K. Visceral fat accumulation and cardiovascular disease. Obes Res 1995; 3 Suppl 5:645S-7S; PMID:8653544; http://dx.doi.org/10.1002/j.1550-8528.1995.tb00481.x
   PubMedGoogle Scholar
• Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, Hirschhorn JN, O'Donnell CJ, Fox CS. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010; 51:1979-87; PMID:20336705; http://dx.doi.org/10.1002/hep.23593
   PubMed Web of Science ®Google Scholar
• Porter SA, Massaro JM, Hoffmann U, Vasan RS, O’Donnel CJ, Fox CS. Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care 2009; 32:1068-75; PMID:19244087; http://dx.doi.org/10.2337/dc08-2280
   PubMed Web of Science ®Google Scholar
• Snijder MB, Visser M, Dekker JM, Goodpaster BH, Harris TB, Kritchevsky SB, De Rekeneire N, Kanaya AM, Newman AB, Tylavsky FA, et al. Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia 2005; 48:301-8; PMID:15660262; http://dx.doi.org/10.1007/s00125-004-1637-7
   PubMed Web of Science ®Google Scholar
• McLaughlin T, Lamendola C, Liu A, Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab 2011; 96:E1756-60; PMID:21865361; http://dx.doi.org/10.1210/jc.2011-0615
   PubMed Web of Science ®Google Scholar
• Koster A, Stenholm S, Alley DE, Kim LJ, Simonsick EM, Kanaya AM, Visser M, Houston DK, Nicklas BJ, Tylavsky FA, et al. Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring) 2010; 18:2354-61; PMID:20395951; http://dx.doi.org/10.1038/oby.2010.86
   PubMed Web of Science ®Google Scholar
• Gallagher D, Kelley DE, Yim JE, Spence N, Albu J, Boxt L, Pi-Sunyer FX, Heshka S. Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr 2009; 89:807-14; PMID:19158213; http://dx.doi.org/10.3945/ajcn.2008.26955
   PubMed Web of Science ®Google Scholar
• Yim JE, Heshka S, Albu JB, Heymsfield S, Gallagher D. Femoral-gluteal subcutaneous and intermuscular adipose tissues have independent and opposing relationships with CVD risk. J Appl Physiol 2008; 104:700-7; PMID:18079271; http://dx.doi.org/10.1152/japplphysiol.01035.2007
   PubMed Web of Science ®Google Scholar
• Manolopoulos KN, Karpe F, Frayn KN. Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 2010; 34:949-59; PMID:20065965
   PubMed Web of Science ®Google Scholar
• Foster MT, Pagliassotti MJ. Metabolic alterations following visceral fat removal and expansion: Beyond anatomic location. Adipocyte 2012; 1:192-9; PMID:23700533; http://dx.doi.org/10.4161/adip.21756
   PubMedGoogle Scholar
• Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J Clin Invest 2004; 113:1582-8; PMID:15173884; http://dx.doi.org/10.1172/JCI21047
   PubMed Web of Science ®Google Scholar
• van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, London R, Peduto T, Chisholm DJ, George J. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008; 48:449-57; PMID:18627003; http://dx.doi.org/10.1002/hep.22350
   PubMed Web of Science ®Google Scholar
• Clore JN, Stillman JS, Li J, O’Keefe SJ, Levy JR. Differential effect of saturated and polyunsaturated fatty acids on hepatic glucose metabolism in humans. Am J Physiol Endocrinol Metab 2004; 287:E358-65; PMID:15082421; http://dx.doi.org/10.1152/ajpendo.00360.2003
   PubMedGoogle Scholar
• Laaksonen DE, Lakka TA, Lakka HM, Nyyssonen K, Rissanen T, Niskanen LK, Salonen JT. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med 2002; 19:456-64; PMID:12060056; http://dx.doi.org/10.1046/j.1464-5491.2002.00707.x
   PubMed Web of Science ®Google Scholar
• Tremblay AJ, Despres JP, Piche ME, Nadeau A, Bergeron J, Almeras N, Tremblay A, Lemieux S. Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome. Metabolism 2004; 53:310-7; PMID:15015142; http://dx.doi.org/10.1016/j.metabol.2003.10.011
   PubMedGoogle Scholar
• Clore JN, Allred J, White D, Li J, Stillman J. The role of plasma fatty acid composition in endogenous glucose production in patients with type 2 diabetes mellitus. Metabolism 2002; 51:1471-7; PMID:12404200; http://dx.doi.org/10.1053/meta.2002.35202
   PubMedGoogle Scholar
• Mollard RC, Senechal M, Macintosh AC, Hay J, Wicklow BA, Wittmeier KD, Sellers EA, Dean HJ, Ryner L, Berard L, et al. Dietary determinants of hepatic steatosis and visceral adiposity in overweight and obese youth at risk of type 2 diabetes. Am J Clin Nutr 2014; 99:804-12; PMID:24522441; http://dx.doi.org/10.3945/ajcn.113.079277
   PubMedGoogle Scholar
• Wang D, Wei Y, Pagliassotti MJ. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 2006; 147:943-51; PMID:16269465; http://dx.doi.org/10.1210/en.2005-0570
   PubMed Web of Science ®Google Scholar
• Wei Y, Wang D, Topczewski F, Pagliassotti MJ. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab 2006; 291:E275-81; PMID:16492686; http://dx.doi.org/10.1152/ajpendo.00644.2005
   PubMed Web of Science ®Google Scholar
• Gentile CL, Nivala AM, Gonzales JC, Pfaffenbach KT, Wang D, Wei Y, Jiang H, Orlicky DJ, Petersen DR, Pagliassotti MJ, et al. Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. Am J Physiol Regul Integr Comp Physiol 2011; 301:R1710-22; PMID:21957160; http://dx.doi.org/10.1152/ajpregu.00677.2010
   PubMedGoogle Scholar
• Malcom GT, Bhattacharyya AK, Velez-Duran M, Guzman MA, Oalmann MC, Strong JP. Fatty acid composition of adipose tissue in humans: differences between subcutaneous sites. Am J Clin Nutr 1989; 50:288-91; PMID:2756915
   PubMed Web of Science ®Google Scholar
• Garaulet M, Perez-Llamas F, Perez-Ayala M, Martinez P, de Medina FS, Tebar FJ, Zamora S. Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity. Am J Clin Nutr 2001; 74:585-91; PMID:11684525
   PubMed Web of Science ®Google Scholar
• Schoen RE, Evans RW, Sankey SS, Weissfeld JL, Kuller L. Does visceral adipose tissue differ from subcutaneous adipose tissue in fatty acid content? Int J Obes Relat Metab Disord 1996; 20:346-52; PMID:8680462
   PubMed Web of Science ®Google Scholar
• Sato D, Nakamura T, Tsutsumi K, Shinzawa G, Karimata T, Okawa T, Feng Z, Kusunoki M. Site dependency of fatty acid composition in adipose triacylglycerol in rats and its absence as a result of high-fat feeding. Metabolism 2012; 61:92-8; PMID:21696790; http://dx.doi.org/10.1016/j.metabol.2011.05.012
   PubMedGoogle Scholar
• Nivala AM, Reese L, Frye M, Gentile CL, Pagliassotti MJ. Fatty acid-mediated endoplasmic reticulum stress in vivo: differential response to the infusion of Soybean and Lard Oil in rats. Metabolism 2013; 62:753-60; PMID:23312405; http://dx.doi.org/10.1016/j.metabol.2012.12.001
   PubMedGoogle Scholar
• Nakamura S, Takamura T, Matsuzawa-Nagata N, Takayama H, Misu H, Noda H, Nabemoto S, Kurita S, Ota T, Ando H, et al. Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. J Biol Chem 2009; 284:14809-18; PMID:19332540; http://dx.doi.org/10.1074/jbc.M901488200
   PubMed Web of Science ®Google Scholar
• Gentile CL, Frye M, Pagliassotti MJ. Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease. Antioxid Redox Signal 2011; 15:505-21; PMID:21128705; http://dx.doi.org/10.1089/ars.2010.3790
   PubMed Web of Science ®Google Scholar
• Shulman GI. Cellular mechanisms of insulin resistance in humans. Am J Cardiol 1999; 84:3J-10J; PMID:10418851; http://dx.doi.org/10.1016/S0002-9149(99)00350-1
   PubMed Web of Science ®Google Scholar
• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221-31; PMID:11961152; http://dx.doi.org/10.1056/NEJMra011775
   PubMed Web of Science ®Google Scholar
• Beysen C, Karpe F, Fielding BA, Clark A, Levy JC, Frayn KN. Interaction between specific fatty acids, GLP-1 and insulin secretion in humans. Diabetologia 2002; 45:1533-41; PMID:12436337; http://dx.doi.org/10.1007/s00125-002-0964-9
   PubMed Web of Science ®Google Scholar
• Dobbins RL, Szczepaniak LS, Myhill J, Tamura Y, Uchino H, Giacca A, McGarry JD. The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats. Diabetes 2002; 51:1825-33; PMID:12031970; http://dx.doi.org/10.2337/diabetes.51.6.1825
   PubMed Web of Science ®Google Scholar
• Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37:911-7; PMID:13671378; http://dx.doi.org/10.1139/o59-099
   PubMedGoogle Scholar
• Kim DH, Sandoval D, Reed JA, Matter EK, Tolod EG, Woods SC, Seeley RJ. The role of GM-CSF in adipose tissue inflammation. Am J Physiol Endocrinol Metab 2008; 295:E1038-46; PMID:18765677; http://dx.doi.org/10.1152/ajpendo.00061.2008
   PubMed Web of Science ®Google Scholar